Biocon Biologics recently announced that it would manufacture and supply insulin glargine pens to Civica under a multi-year ...

California Gov. Gavin Newsom, a leading Democratic critic of President Donald Trump, says he'll consider running for the ...

The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell an affordable version of the drug to residents, Gov. Gavin Newsom announced ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...

California will soon become the first state to offer its own affordable insulin, with Gov. Gavin Newsom announcing that CalRx ...

California Gov. Gavin Newsom announces CalRx-branded insulin glargine pens available beginning Jan. 1, 2026, at a suggested retail price of no more than $55 per five-pack, or $11 per pen, during a ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell ...

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1. The insulin is from a state-branded form of the medicine, CalRx. Lawmakers ...

The new CalRx insulin will work as a generic version of glargine and could save patients $2,000 to $4,000 per year ...